{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:32:40Z","timestamp":1793251960617,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbrc.2026.154778","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:52:30Z","timestamp":1792507950000},"page":"154778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A transcriptomic resilience gap between the substantia nigra and cerebellum is associated with regional vulnerability in Parkinson's disease"],"prefix":"10.1016","volume":"840","author":[{"given":"Fahad Hassan","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Sig","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7666-313X","authenticated-orcid":false,"given":"Seung Hyeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Rae","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jae","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyang","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na Young","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Joo","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154778_bib1","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3390\/cells14151161","article-title":"Parkinson's disease: bridging gaps, building biomarkers, and reimagining clinical translation","volume":"14","author":"Tanaka","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.154778_bib2","first-page":"239","article-title":"Aging, cellular senescence and Parkinson's disease","volume":"15","author":"Ma","year":"2025","journal-title":"J. Park. Dis"},{"key":"10.1016\/j.bbrc.2026.154778_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1535682","article-title":"Recent advances in nanotechnology for Parkinson's disease: diagnosis, treatment, and future perspectives","volume":"12","author":"Yadav","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.bbrc.2026.154778_bib4","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/brain\/awae365","article-title":"Lewy pathology formation in patient-derived GBA1 Parkinson's disease midbrain organoids","volume":"148","author":"Frattini","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.bbrc.2026.154778_bib5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s13287-025-04660-4","article-title":"Three-dimensional midbrain organoids: a next-generation tool for Parkinson's disease modelling and drug discovery","volume":"16","author":"Elvira","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bbrc.2026.154778_bib6","article-title":"Advanced brain aging, selective vulnerability in gray matter, and cognition in Parkinson's disease, Journals Gerontol","volume":"80","author":"Cai","year":"2025","journal-title":"Ser. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.bbrc.2026.154778_bib7","first-page":"10","article-title":"Nigrostriatal dopaminergic vulnerability in Parkinson's disease: neuroprotective strategies","author":"Santana-Rom\u00e1n","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.bbrc.2026.154778_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature11405","article-title":"An anatomically comprehensive atlas of the adult human brain transcriptome","volume":"489","author":"Hawrylycz","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154778_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128651","article-title":"Evidence for immune response, axonal dysfunction and reduced endocytosis in the Substantia nigra in early stage parkinson's disease","volume":"10","author":"Dijkstra","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154778_bib10","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1038\/s41467-020-17876-0","article-title":"A single-cell atlas of the human substantia nigra reveals cell-specific pathways associated with neurological disorders","volume":"11","author":"Agarwal","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154778_bib11","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/brain\/awab446","article-title":"Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state","volume":"145","author":"Smaji\u0107","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.bbrc.2026.154778_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2026.103179","article-title":"How to discover novel genes that cause Parkinson's disease","volume":"98","author":"Farrer","year":"2026","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.bbrc.2026.154778_bib13","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/antiox13101183","article-title":"A single-cell atlas of the substantia nigra reveals therapeutic effects of icaritin in a rat model of Parkinson's disease","volume":"13","author":"Wu","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbrc.2026.154778_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","article-title":"Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions","volume":"8","author":"Dong-Chen","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.154778_bib15","article-title":"Molecular profiling of human substantia nigra identifies diverse neuron types associated with vulnerability in Parkinson's disease","volume":"10","author":"Wang","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbrc.2026.154778_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105866","article-title":"Baseline \u03b1-synuclein seeding activity and disease progression in sporadic and genetic Parkinson's disease in the PPMI cohort","volume":"119","author":"Schumacher","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbrc.2026.154778_bib17","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson's disease: mechanisms, biomarkers, and therapeutic strategies","author":"Usha Kiran","year":"2025","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.bbrc.2026.154778_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71414-y","article-title":"Functional maintenance of calcium store by ShcB adaptor protein in cerebellar Purkinje cells","volume":"10","author":"Kakizawa","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154778_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13062-025-00702-2","article-title":"Plasma membrane calcium ATPases and cerebellar pathology: what's the role in the ataxia?","volume":"20","author":"Peggion","year":"2025","journal-title":"Biol. Direct"},{"key":"10.1016\/j.bbrc.2026.154778_bib20","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.bbrc.2016.07.020","article-title":"Keeping our calcium in balance to maintain our balance","volume":"483","author":"Mark","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154778_bib21","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The genotype-tissue expression (GTEx) project","volume":"45","author":"Lonsdale","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2026.154778_bib22","first-page":"205","article-title":"A benchmark of gene expression tissue-specificity metrics","volume":"18","author":"Kryuchkova-Mostacci","year":"2017","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.bbrc.2026.154778_bib23","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","article-title":"Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson's disease","volume":"25","author":"Kamath","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbrc.2026.154778_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41588-023-01584-8","article-title":"Multi-ancestry genome-wide association meta-analysis of Parkinson's disease","volume":"56","author":"Kim","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2026.154778_bib25","doi-asserted-by":"crossref","first-page":"D730","DOI":"10.1093\/nar\/gkae1113","article-title":"The STRING database in 2025: protein networks with directionality of regulation","volume":"53","author":"Szklarczyk","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.154778_bib26","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/mds.23305","article-title":"Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model","volume":"25","author":"Kingsbury","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbrc.2026.154778_bib27","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.154778_bib28","doi-asserted-by":"crossref","first-page":"D1467","DOI":"10.1093\/nar\/gkae1128","article-title":"Open targets platform: facilitating therapeutic hypotheses building in drug discovery","volume":"53","author":"Buniello","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.154778_bib29","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3390\/genes15111431","article-title":"Tracing ALS degeneration: insights from spinal cord and cortex transcriptomes","volume":"15","author":"Sneha","year":"2024","journal-title":"Genes"},{"key":"10.1016\/j.bbrc.2026.154778_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13073-022-01133-8","article-title":"Illuminating links between cis-regulators and trans-acting variants in the human prefrontal cortex","volume":"14","author":"Liu","year":"2022","journal-title":"Genome Med."},{"key":"10.1016\/j.bbrc.2026.154778_bib31","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/brain\/awac022","article-title":"Establishing gene regulatory networks from Parkinson's disease risk loci","volume":"145","author":"Farrow","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.bbrc.2026.154778_bib32","article-title":"Modeling cis-regulatory variation in human brain enhancers across a large Parkinson's Disease cohort","author":"Sigalova","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.bbrc.2026.154778_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115193","article-title":"Role of substantia Nigra dopaminergic neurons in respiratory modulation and limitations of levodopa in Parkinson's disease","volume":"387","author":"Miranda","year":"2025","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbrc.2026.154778_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s42003-026-09664-1","article-title":"The genetic architecture of human cerebellar morphology supports a key role for the cerebellum in human evolution and psychopathology","volume":"9","author":"Moberget","year":"2026","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbrc.2026.154778_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s40478-025-02107-8","article-title":"Distinct spatial transcriptomic patterns of substantia Nigra in Parkinson disease and Parkinsonian subtype of multiple system atrophy","volume":"13","author":"Shin","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbrc.2026.154778_bib36","article-title":"Spatio-molecular profiles shape the human cerebellar hierarchy along the sensorimotor-association axis","volume":"43","author":"Wang","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2026.154778_bib37","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1038\/s41598-022-08528-y","article-title":"Disrupted connectivity in the olfactory bulb-entorhinal cortex-dorsal hippocampus circuit is associated with recognition memory deficit in Alzheimer's disease model","volume":"12","author":"Salimi","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154778_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/alz.072623","article-title":"The pattern of hippocampus and entorhinal cortex subregion atrophy in early alzheimer's disease","volume":"19","author":"Lacz\u00f3","year":"2023","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.bbrc.2026.154778_bib39","first-page":"799","article-title":"Spatiotemporal characterization of disease-associated neurons in the entorhinal cortex-hippocampal circuit during Alzheimer's disease progression","volume":"16","author":"Ma","year":"2025","journal-title":"Protein Cell"},{"key":"10.1016\/j.bbrc.2026.154778_bib40","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41419-018-0294-6","article-title":"ALS-related human cortical and motor neurons survival is differentially affected by Sema3A","volume":"9","author":"Birger","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.154778_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2025.102809","article-title":"Cortical hyperexcitability drives dying forward amyotrophic lateral sclerosis symptoms and pathology in mice","volume":"252","author":"Haidar","year":"2025","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbrc.2026.154778_bib42","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1042\/BST20231061","article-title":"Dopamine synthesis and transport: current and novel therapeutics for parkinsonisms","volume":"52","author":"Tai","year":"2024","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbrc.2026.154778_bib43","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1038\/s41467-024-51837-1","article-title":"Propofol disrupts the functional core-matrix architecture of the thalamus in humans","volume":"15","author":"Huang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154778_bib44","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.bja.2020.11.035","article-title":"Propofol sedation-induced alterations in brain connectivity reflect parvalbumin interneurone distribution in human cerebral cortex","volume":"126","author":"Craig","year":"2021","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.bbrc.2026.154778_bib45","doi-asserted-by":"crossref","first-page":"14593","DOI":"10.1073\/pnas.0404887101","article-title":"Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications","volume":"101","author":"Arnon","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbrc.2026.154778_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577091","article-title":"Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model","volume":"339","author":"Nystad","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbrc.2026.154778_bib47","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41398-026-04125-z","article-title":"Prenatal valproic acid exposure alters striatal proteomic signatures associated with autism spectrum disorder in mice","volume":"16","author":"Jo","year":"2026","journal-title":"Transl. Psychiatry"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26015445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26015445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:00:27Z","timestamp":1793250027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26015445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":47,"alternative-id":["S0006291X26015445"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154778","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A transcriptomic resilience gap between the substantia nigra and cerebellum is associated with regional vulnerability in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154778"}}